As senior business development executive for Southern Research’s Drug Development division, Molly Gleizes implements her technical sales expertise to pair Southern Research’s capabilities in pre-clinical research with development companies’ needs to bring effective therapies to market.
Gleizes comes to SR from Biovectra/Mallinckrodt Pharmaceuticals, where she led western U.S. business development, identifying contract development and manufacturing opportunities and serving as the expert field liaison to the client. She is a business development professional with over 15 years of experience selling laboratory, diagnostic, and chemical development services to early-to-late stage clinical and commercial pharmaceutical and biotechnology companies. Additionally, she has extensive practice in closing complex multi-level deals, building a business from the ground up, and forming integrated collaborations. She has held leadership roles at several pharmaceutical and biotech companies including Dixie Chemical, Ricerca Biosciences, and ALS Columbia Analytical Services Inc.
Gleizes has a proven track record of taking many groups from start-up status into a successful pipeline of repeat business. She attributes much of her success to the long-lasting relationships she has maintained throughout her career and a gifted ability to make connections and find patterns.
Gleizes earned a Bachelor of Science in cell and molecular biology with a specialization in biochemistry from the University of Washington School of Medicine. She received a Master of Business Administration in international business from American InterContinental University.